SHARLOTTE MANLEY: Open Payments
NPI 1457843781 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,651 in 140 payments from 20 companies in 2025. Trend: 2023 $1,989 · 2024 $2,547 · 2025 $2,651
Food & beverage: $2,574Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $626 |
| Janssen Biotech, Inc. | 19 | $386 |
| Regeneron Healthcare Solutions, Inc. | 8 | $288 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $238 |
| Aimmune Therapeutics, Inc. | 7 | $178 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $178 |
| PFIZER INC. | 7 | $167 |
| REVANCE THERAPEUTICS, INC. | 1 | $148 |
| Lilly USA, LLC | 4 | $68 |
| Celltrion USA Inc. | 3 | $65 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, ZENPEP, XIFAXAN, ENTYVIO, RINVOQ, XELJANZ.
Industry payments across TN — which companies pay providers there.
